Overall a solid result and outlook. The usual suspects will whinge about institutional life sales being down, but enough momentum elsewhere to easily account for this. Not many companies are providing double guidance for double digit profit growth for the next year. Reckon the SP should be $8 plus but doubt it will climb there in near term because the market just doesn't rate the company.
Ann: 2023 Investor Presentation and outlook, page-7
Add CGF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.15 |
Change
-0.090(1.44%) |
Mkt cap ! $4.250B | |||
| Open | High | Low | Value | Volume |
| $6.19 | $6.23 | $6.14 | $33.44M | 5.426M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 95007 | $6.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.19 | 41344 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| CGF (ASX) Chart |